Literature DB >> 19052104

Omega-3 fatty acid rich diet prevents diabetic renal disease.

Joseph H Garman1, Susan Mulroney, Michaele Manigrasso, Elizabeth Flynn, Christine Maric.   

Abstract

Omega-3 polyunsaturated fatty acids (n-3 PUFA) show beneficial effects in cardiovascular disease, IgA, and diabetic nephropathy; however, the mechanisms underlying these benefits are unknown. The study was performed in male Sprague-Dawley rats randomly divided into four treatment groups: nondiabetic (ND), streptozotocin-induced diabetic (D), diabetic and fed a high n-3 PUFA diet (D+canola), and diabetic and fed a high n-6 (omega-6) PUFA diet (D+corn). Study treatments were carried out for 30 wk. D+canola significantly decreased diabetes-associated increases in urine albumin excretion (ND 17.8 +/- 6.4; D 97.3 +/- 9.4; D+canola 8.3 +/- 2.2 mg/day); systolic blood pressure (ND 153 +/- 9; D 198 +/- 7; D+canola 162 +/- 9 mmHg); glomerulosclerosis (ND 0.6 +/- 0.2; D 1.8 +/- 0.2; D+canola 0.8 +/- 0.1 AU); and tubulointerstitial fibrosis in the renal cortex (ND 1.2 +/- 0.2; D 2.0 +/- 0.2; D+canola 1.1 +/- 0.1) and the inner stripe of the outer medulla (ND 1.0 +/- 0.2; D 2.1 +/- 0.2; D+canola 1.1 +/- 0.2 AU). D+corn also exerted renoprotection, but not to the same degree as D+canola (urine albumin excretion, 33.8 +/- 6.1 mg/day; systolic blood pressure, D+corn 177 +/- 6 mmHg; glomerulosclerosis, D+corn 1.2 +/- 0.3 AU; cortical tubulointerstitial fibrosis, D+corn 1.6 +/- 0.1 AU; medullary tubulointerstitial fibrosis, D+corn 1.5 +/- 0.1 AU). In addition, D+canola attenuated D-associated increase in collagen type I and type IV, IL-6, MCP-1, transforming growth factor-beta, and CD68 expression. These observations indicate a beneficial effect of high dietary intake of n-3 PUFA in reducing diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052104     DOI: 10.1152/ajprenal.90326.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  23 in total

1.  Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.

Authors:  Hanna Shevalye; Yury Maksimchyk; Pierre Watcho; Irina G Obrosova
Journal:  Biochim Biophys Acta       Date:  2010-07-16

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

Review 3.  Effects of polyunsaturated fatty acid consumption in diabetic nephropathy.

Authors:  Haim Shapiro; Miryam Theilla; Joelle Attal-Singer; Pierre Singer
Journal:  Nat Rev Nephrol       Date:  2010-12-07       Impact factor: 28.314

Review 4.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

5.  Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.

Authors:  Ian H de Boer; Leila R Zelnick; Julie Lin; Debra Schaumberg; Lu Wang; John Ruzinski; Georgina Friedenberg; Julie Duszlak; Vadim Y Bubes; Andrew N Hoofnagle; Ravi Thadhani; Robert J Glynn; Julie E Buring; Howard D Sesso; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-09-30       Impact factor: 2.226

6.  Dietary avocado oil supplementation attenuates the alterations induced by type I diabetes and oxidative stress in electron transfer at the complex II-complex III segment of the electron transport chain in rat kidney mitochondria.

Authors:  Omar Ortiz-Avila; Carlos Alberto Sámano-García; Elizabeth Calderón-Cortés; Ismael H Pérez-Hernández; Ricardo Mejía-Zepeda; Alain R Rodríguez-Orozco; Alfredo Saavedra-Molina; Christian Cortés-Rojo
Journal:  J Bioenerg Biomembr       Date:  2013-02-27       Impact factor: 2.945

7.  Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.

Authors:  Hanna Shevalye; Roman Stavniichuk; Weizheng Xu; Jie Zhang; Sergey Lupachyk; Yury Maksimchyk; Viktor R Drel; Elizabeth Z Floyd; Barbara Slusher; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

8.  Effect of PUFA on patients with hypertension: a hospital based study.

Authors:  Nisha Shantakumari; Rasha Ali Eldeeb; Salwa Abdelzaher Mabrouk Ibrahim; Jayadevan Sreedharan; Sufian Otoum
Journal:  Indian Heart J       Date:  2014-06-06

9.  Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.

Authors:  Viktor R Drel; Weizheng Xu; Jie Zhang; Ivan A Pavlov; Hanna Shevalye; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2009-10-23       Impact factor: 4.736

Review 10.  New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease?

Authors:  Francine K Welty
Journal:  Curr Diab Rep       Date:  2019-01-25       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.